Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/09/2010 | US20100311124 Methods and compositions for inactivating glutamine synthetase gene expression |
12/09/2010 | US20100311121 Regulatory nucleic acid elements |
12/09/2010 | US20100311120 Human cytokine receptor |
12/09/2010 | US20100311117 Nucleic acids isolated from the intestine |
12/09/2010 | US20100311082 Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals |
12/09/2010 | US20100311075 Human sodium-dependent bile acid transporter proteins |
12/09/2010 | US20100311059 Gender-specific separation of sperm cells and embryos |
12/09/2010 | US20100311051 Calcium-binding photoprotein, gene encoding the same and use thereof |
12/09/2010 | US20100311036 Methods for Augmentation of Cell Cryopreservation |
12/09/2010 | US20100310753 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
12/09/2010 | US20100310710 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
12/09/2010 | US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues |
12/09/2010 | US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4 |
12/09/2010 | US20100310645 Methods for inhibiting tumor cell proliferation |
12/09/2010 | US20100310643 Cd133 epitopes |
12/09/2010 | US20100310639 Immuno-modulatory composition |
12/09/2010 | US20100310633 Chitinosanase |
12/09/2010 | US20100310630 Coated surface for cell culture |
12/09/2010 | US20100310627 Xenotransplant for Stroke Therapy |
12/09/2010 | US20100310601 Adeno-Associated Virus Materials and Methods |
12/09/2010 | US20100310597 Anti-ofloxacin monoclonal antibody and immunoassay of ofloxacin using the same |
12/09/2010 | US20100310591 Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA |
12/09/2010 | US20100310588 Regulatory t cells suppress autoimmunity |
12/09/2010 | US20100310587 Immunomodulatory compositions |
12/09/2010 | US20100310584 Antigen |
12/09/2010 | US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
12/09/2010 | US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy |
12/09/2010 | US20100310573 Anti-cd4 antibody |
12/09/2010 | US20100310561 Natriuretic fusion proteins |
12/09/2010 | US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors |
12/09/2010 | US20100310546 ACE2 Polypeptide |
12/09/2010 | US20100310544 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues |
12/09/2010 | US20100310537 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310536 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310535 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310533 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens |
12/09/2010 | US20100310532 Gene targets in anti-aging therapy and tissue repair |
12/09/2010 | US20100310531 Peptide-coated cell localization to diseased or damaged tissues and methods related thereto |
12/09/2010 | US20100310529 Extracellular matrix from pluripotent cells |
12/09/2010 | US20100310528 Vector System for Site-Specific Integration |
12/09/2010 | US20100310527 Liposome mediated delivery of lineage determining factors |
12/09/2010 | US20100310526 Cosmetic method for increasing the pigmentation of skin using melanocyte precursor cells |
12/09/2010 | US20100310525 Wnt pathway stimulation in reprogramming somatic cells |
12/09/2010 | US20100310524 Compositions Suitable for Treatment of Spinal Disease, Disorder or Condition |
12/09/2010 | US20100310523 Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene |
12/09/2010 | US20100310521 Polynucleotide sequence for the inhibition of phospholamban synthesis |
12/09/2010 | US20100310519 Incorporation of Active Molecules into Microalga |
12/09/2010 | US20100310516 Duplexed Parvovirus Vectors |
12/09/2010 | US20100310515 Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site |
12/09/2010 | US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME |
12/09/2010 | US20100310484 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
12/09/2010 | US20100310474 Protein cages for the delivery of medical imaging and therapeutic agents |
12/09/2010 | US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies |
12/09/2010 | US20100310469 Vaccine immunotherapy for immune suppressed patients |
12/09/2010 | US20100310464 Antibodies |
12/09/2010 | US20100310463 Anti-EpCAM Antibodies |
12/09/2010 | US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis |
12/09/2010 | US20100307950 Method for harvesting fat cells from a fat-fluid mixture |
12/09/2010 | CA2764589A1 Gene capable of improving material productivity in seed and method for use thereof |
12/09/2010 | CA2764563A1 Gene capable of increasing seed protein content and method of use thereof |
12/09/2010 | CA2764448A1 Polypeptide having d-lactate dehydrogenase activity, polynucleotide encoding the polypeptide, and process for production of d-lactic acid |
12/09/2010 | CA2764373A1 Reprogramming t cells and hematopoietic cells |
12/09/2010 | CA2764370A1 Fucosylation-deficient cells |
12/09/2010 | CA2763977A1 Human milk peptides |
12/09/2010 | CA2762590A1 Bioartificial lung |
12/08/2010 | EP2258857A1 TDP-43 transgenic mouse model for frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) |
12/08/2010 | EP2258849A1 Mammalian receptor proteins; related reagents and methods |
12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
12/08/2010 | EP2258847A2 Futher novel forms of interfering RNA molecules |
12/08/2010 | EP2258843A1 Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof |
12/08/2010 | EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/08/2010 | EP2258839A1 Nocardiopsis proteases |
12/08/2010 | EP2258838A1 Nocardiopsis proteases |
12/08/2010 | EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
12/08/2010 | EP2258833A2 Isolation of a new cardiac stem cell population |
12/08/2010 | EP2258726A1 High affinity human antibodies to c-erbB-2 |
12/08/2010 | EP2258725A2 Cytokine receptor zcytor17 |
12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |
12/08/2010 | EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/08/2010 | EP2258383A2 Antigenic peptides derived from telomerase |
12/08/2010 | EP2258379A1 Use of platelet rich plasma composition |
12/08/2010 | EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer |
12/08/2010 | EP2258174A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258173A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258172A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258171A2 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258170A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258169A2 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258168A2 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa |
12/08/2010 | EP2258166A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification |
12/08/2010 | EP2257625A2 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
12/08/2010 | EP2257621A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
12/08/2010 | EP2257620A1 Method for increasing recloning efficiency |
12/08/2010 | EP1942739B1 Conditionally immortalized long-term adult stem cells and methods of making and using such cells |
12/08/2010 | EP1673397B1 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
12/08/2010 | EP1652925B1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION |
12/08/2010 | EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof |
12/08/2010 | EP1551867B1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
12/08/2010 | EP1496109B1 Process for producing cytotoxic lymphocyte |
12/08/2010 | EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence |